ReviewFrontiers in oncology2022

Targeting Epigenetic Regulatory Enzymes for Cancer Therapeutics: Novel Small-Molecule Epidrug Development.

Ye Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.